The National Pharmacy Association (NPA) has welcomed the European Commission's decision to widen access to orlistat, giving pharmacists the ability to help people who are overweight and obese with a well-proven and safe medicine.
Commenting on the decision John Turk, NPA Chief Executive said: "Our members report that many people seek advice from pharmacists on how best they can lose weight. By making orlistat a pharmacy medicine, pharmacists now have a new way of encouraging safe, steady and sustained weight loss in the general public."
